Drug and Device Development

Shares of Apricus tank after FDA declines to OK erectile…

Shares of Apricus tank after FDA declines to OK erectile…

Published 16/02/2018

FILE PHOTO: - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo(Reuters) - [more…]

Apricus says FDA declines to approve erectile dysfunction cream

Apricus says FDA declines to approve erectile dysfunction cream

Published 16/02/2018

FILE PHOTO: - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo(Reuters) - [more…]

AstraZeneca is sued by Array BioPharma over cancer drug royalties

AstraZeneca is sued by Array BioPharma over cancer drug royalties

Published 02/02/2018

NEW YORK (Reuters) - Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer [more…]

AstraZeneca’s three-in-one inhaler helps COPD patients in trial

AstraZeneca’s three-in-one inhaler helps COPD patients in trial

Published 26/01/2018

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo(Reuters) - AstraZeneca said an inhaler for chronic [more…]

Aclaris’s drug to treat common skin growth gets FDA nod

Aclaris’s drug to treat common skin growth gets FDA nod

Published 15/12/2017

(Reuters) - Aclaris Therapeutics Inc’s drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug [more…]

FDA allows Alnylam to restart hemophilia treatment trials

FDA allows Alnylam to restart hemophilia treatment trials

Published 15/12/2017

(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a [more…]

U.S. scientists take step toward creating artificial life

U.S. scientists take step toward creating artificial life

Published 29/11/2017

A scientist does research in a lab in San Diego, California April 26, 2009. REUTERS/Mike BlakeCHICAGO (Reuters) - In a major step toward creating artificial [more…]

Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination

Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination

Published 23/10/2017

Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery. [more…]

Regeneron-Sanofi drug succeeds mid-stage study

Regeneron-Sanofi drug succeeds mid-stage study

Published 16/10/2017

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. [more…]

Exelixis drug improves overall survival in liver cancer patients

Exelixis drug improves overall survival in liver cancer patients

Published 16/10/2017

Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. [more…]